Display Settings:

Format

Send to:

Choose Destination
Accession: PRJNA165681 ID: 165681

Homo sapiens (human)

Mid-gestational gene expression profile in placenta and link to pregnancy complications

See Genome Information for Homo sapiens
Data on the temporal dynamics of human placental gene expression is scarce. We have completed the first whole-genome profiling of human placental gene expression dynamics (GeneChips, Affymetrix®) from early to mid- gestation (10 samples; gestational weeks 5 to 18) and report 154 genes with considerable change in transcript levels (FDR P<0.1). Functional enrichment analysis revealed >200 GO categories that are statistically over-represented among 105 genes with dynamically increasing transcript levels. Analysis in an extended sample (n=43; gestational weeks 5 to 41) conformed a highly significant (FDR P<0.05) expressional peak in mid-gestation placenta for ten genes: BMP5, CCNG2, CDH11, FST, GATM, GPR183, ITGBL1, PLAGL1, SLC16A10, STC1. A central hypothesis of our study states that the aberrant expression of genes characteristic to mid-gestation placenta may contribute to affected fetal growth, maternal preeclampsia (PE) or gestational diabetes (GD). The gene STC1 coding for Stanniocalcin 1 (STC1) was identified with a sharp placental expressional peak in mid-gestation, increased mRNA levels at term and significantly elevated STC1 protein levels in post-partum maternal plasma in all pregnancy complications. The highest STC1 levels were identified in women, who developed simultaneously PE and delivered an SGA baby (median 731 vs 418 pg/ml in controls; P=0.001). CCNG2 and LYPD6 exhibited significantly increased placental mRNA expression and enhanced intensity of immunohistochemistry staining in placental sections all studied in GD and PE cases. Aberrant expression of mid-gestation specific genes in pregnancy complications at term indicates the importance of the fine-scale tuning of the temporal dynamics of transcription regulation in placenta. Observed significantly elevated plasma STC1 in complicated pregnancies warrants further investigations of its potential as a biomarker. Interestingly, a majority of genes with high expression in mid-gestation placenta have also been implicated in adult complex disease. This observation promotes a recently opened discussion on the role of placenta in developmental programming. Overall design: 4 samples; this submission is extension of our earlier study (accession GSE22490).
AccessionPRJNA165681; GEO: GSE37901
Data TypeTranscriptome or Gene expression
ScopeMultiisolate
OrganismHomo sapiens[Taxonomy ID: 9606]
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo; Homo sapiens
PublicationsUusküla L et al., "Mid-gestational gene expression profile in placenta and link to pregnancy complications.", PLoS One, 2012;7(11):e49248
SubmissionRegistration date: 11-May-2012
Department of Pathophysiology, University of Tartu
RelevanceMedical
Project Data:
Resource NameNumber
of Links
Publications
PubMed1
PMC1
Other datasets
GEO DataSets1
GEO Data Details
ParameterValue
Data volume, Spots218700
Data volume, Processed Mbytes4
Data volume, Supplementary Mbytes19

Supplemental Content

Recent activity

  • Homo sapiens
    Homo sapiens
    Mid-gestational gene expression profile in placenta and link to pregnancy complications
    BioProject
  • Drosophila pseudoobscura
    Drosophila pseudoobscura
    Drosophila pseudoobscura Transcriptome or Gene expression
    BioProject
  • Metabacillus sp. KUDC1714
    Metabacillus sp. KUDC1714
    Metabacillus sp. KUDC1714 Genome sequencing
    BioProject
  • Porphyromonas gingivalis ATCC 33277
    Porphyromonas gingivalis ATCC 33277
    Porphyromonas gingivalis 33277 wild-type vs Fur orthologue Har isogenic mutant ECR455
    BioProject

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center